Why Is BLUE BIRD CORP (BLBD) Stock Down Today?

Blue Bird Corp (BLBD) shares fell 6.41% to $64.35 in morning trading on May 20 as a price target cut by Roth Capital weighed on investor sentiment. The stock opened near its 52-week high but quickly declined amid the bearish analyst move. The stock’s recent earnings report, which showed mixed results, and ongoing analyst activity also contributed to the session’s downward momentum.

What Happened

Roth Capital lowered its price target for Blue Bird from $94 to $93, signaling a bearish shift in its outlook for the stock. This move came amid a broader landscape of analyst coverage that included both upgrades and downgrades. Earlier in the week, DA Davidson and Needham maintained their Buy ratings while raising price targets to $91 and $86 respectively. BTIG also raised its target to $95. However, the recent cut from Roth Capital appears to have had a more immediate impact on the stock’s price. Blue Bird reported Q3 adjusted earnings of $1.28 per share, missing the $1.30 estimate, though revenue of $517.16 million beat the $485.72 million forecast. The company affirmed its FY2026 sales guidance of $1.750 billion, above the $1.718 billion estimate.

What The Data Shows

The stock opened at $68.83 and reached an intraday high of $69.71 before declining to a session low of $64.26. The current price of $64.35 represents a significant pullback from its 52-week high of $83.39. Trading volume of 0.2 million shares is 0.4 times the 3-month daily average, suggesting limited immediate follow-through from the analyst move. Blue Bird’s fundamentals remain strong, with a P/E of 8.1, a 13.5% year-to-date revenue increase, and a net margin of 17.5%. The stock’s beta of 1.39 indicates it is more volatile than the broader market. Insiders have been net buyers recently, with one purchase totaling $20,000 reported on May 19.

What To Watch

Blue Bird has no scheduled earnings in the near term. Investors will want to monitor the breadth of analyst coverage and how the market reacts to any further changes in price targets or guidance.